Does Arcutis Biotherapeutics (ARQT) Have the Potential to Rally 45.81% as Wall Street Analysts Expect?

Arcutis Biotherapeutics, Inc. (ARQT) closed the last trading session at $15.52, gaining 8.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $22.63 indicates a 45.8% upside potential.The mean estimate comprises eight short-term price targets with a standard deviation of $3.25. While the lowest estimate of $18.00 indicates a 16% increase from the current price level, the most optimi ...